Rydex Series Trust Europe Advantage Fund Class A (RYAEX)
| 17.78 Net Asset Value | -1.06% 1 Day | +2.30% Year-to-Date | Overall Morningstar Rating |
| Trading-leveraged equity Style or Category | 4.75 Sales Expenses | 1.67% Expense Ratio | High Morningstar Risk Rating™ |
Investment Objective The investment seeks to provide investment results that correlate, before fees and expenses, to the performance of 125% of the fair value of the Europe STOXX 50 ® Index.
The fund employs as its investment strategy a program of investing in the common stock of companies that are generally within the capitalization range of the underlying index and derivative instruments. It will invest at least 80% of its net assets, plus any borrowings for investment purposes, in securities of companies in the underlying index and derivatives and other instruments whose performance is expected to correspond to that of the underlying index. The fund is non-diversified.
Performance
| 1 month | -2.47% | 3 years | +8.28% | |
| 3 months | +1.08% | 5 years | +7.40% | |
| 1 year | +17.21% | Since inception | +2.77% |
Data through --
Peer Comparisonvs. Trading-leveraged equity
| RYAEX | Category | |
|---|---|---|
| Performance 5-yr return | +7.40% | +23.72% |
| Expense ratio | 1.67% | 2.10% |
| Risk 5 year sharpe ratio | 0.50 | 0.94 |
| Net assets | $12.1M | $64.5M |
| Average market cap | $117.3B | -- |
| Average P/E | 16.9 | -- |
| Portfolio turnover | 654% | 654% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
Fund Management and Purchase Info
| Fund family | Rydex Funds |
| Fund manager & tenure | Michael Byrum / 14 Years |
| Minimal initial investment | $2,500.00 |
| Minimum IRA investment | $1,000.00 |
Holdings
| International stock | 63.58% |
| Fixed income | 25.65% |
| Cash | 10.77% |
| U.S. stock | 0.00% |
| Other | 0.00% |
Top 5 SectorsPortfolio weighting
| Financial service | 21.80% |
| Energy | 20.96% |
| Telecommunication | 16.63% |
| Healthcare | 16.00% |
| Industrial materials | 14.03% |
Top 10 HoldingsPortfolio weighting
| -- Guggenheim Strategy I | 24.87% |
| NSRGY Nestle SA ADR | 3.64% |
| NVS Novartis AG ADR | 3.56% |
| RHHBY Roche Holding AG ADR | 3.09% |
| HSBC HSBC Holdings PLC ADR | 2.93% |
| TOT Total SA ADR | 2.49% |
| RDSA Royal Dutch Shell PLC ADR Class A | 2.38% |
| BP BP PLC ADR | 2.37% |
| GSK GlaxoSmithKline PLC ADR | 1.95% |
| SNY Sanofi ADR | 1.90% |
.
